These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22954684)

  • 21. Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767 (-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia.
    Kodidela S; Pradhan SC; Dubashi B; Basu D
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1349-58. PubMed ID: 26335211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism of resistance to methotrexate. NADPH but not NADH stimulation of methotrexate binding to dihydrofolate reductase.
    Kamen BA; Whyte-Bauer W; Bertino JR
    Biochem Pharmacol; 1983 Jun; 32(12):1837-41. PubMed ID: 6882460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro.
    Chu E; Takimoto CH; Voeller D; Grem JL; Allegra CJ
    Biochemistry; 1993 May; 32(18):4756-60. PubMed ID: 8490020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
    Sastry KJ; Chan TS; Rodriguez LV
    Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG; Nowickyj SM; Walker VK
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased dihydrofolate reductase activity in methotrexate-resistant human promyelocytic-leukaemia (HL-60) cells. Lack of correlation between increased activity and overproduction.
    Dedhar S; Hartley D; Goldie JH
    Biochem J; 1985 Feb; 225(3):609-17. PubMed ID: 3856428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
    Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
    J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the gene for human dihydrofolate reductase: an unlikely cause of clinical relapse in pediatric leukemia after therapy with methotrexate.
    Spencer HT; Sorrentino BP; Pui CH; Chunduru SK; Sleep SE; Blakley RL
    Leukemia; 1996 Mar; 10(3):439-46. PubMed ID: 8642859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Characterization of Dihydrofolate Reductase Complexes by Top-Down Ultraviolet Photodissociation Mass Spectrometry.
    Cammarata MB; Thyer R; Rosenberg J; Ellington A; Brodbelt JS
    J Am Chem Soc; 2015 Jul; 137(28):9128-35. PubMed ID: 26125523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH; Goldsmith ME; Ricciardone MD; Levine R; Rubalcaba E; Jolivet J
    Mol Pharmacol; 1986 Jul; 30(1):69-76. PubMed ID: 3724746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
    Miyachi H; Jiao L; Sowers LC; Scanlon KJ
    In Vivo; 1992; 6(1):17-21. PubMed ID: 1385729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia.
    Matherly LH; Taub JW; Ravindranath Y; Proefke SA; Wong SC; Gimotty P; Buck S; Wright JE; Rosowsky A
    Blood; 1995 Jan; 85(2):500-9. PubMed ID: 7812005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
    McGuire JJ; Magee KJ; Russell CA; Canestrari JM
    Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
    Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
    Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.